"GBM" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonPersonalized vaccine shows promise against aggressive brain cancer - WashU Medicine
Personalized vaccine shows promise against aggressive brain cancer WashU Medicine
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: ...
Goldman Sachs Stock Climbs Near Its 1-Year High After a Record GBM Revenue Quarter - TIKR.com
Goldman Sachs Stock Climbs Near Its 1-Year High After a Record GBM Revenue Quarter TIKR.com
Sisters to honor dad lost to glioblastoma with 'Tommy's Trek' race in Danville - WSET
Sisters to honor dad lost to glioblastoma with 'Tommy's Trek' race in Danville WSET
Jason Collins, first openly gay NBA player, dies at 47 after glioblastoma battle - USA Today
Jason Collins, first openly gay NBA player, dies at 47 after glioblastoma battle USA Today
Glioblastoma studies show promise - The University of North Carolina at Chapel Hill
Glioblastoma studies show promise The University of North Carolina at Chapel Hill
The scientist designing a tailored attack on glioblastoma - UCLA Health
The scientist designing a tailored attack on glioblastoma UCLA Health
Deadly brain cancer: all tumors controlled in 3-patient Alpha Tau trial - Stock Titan
Deadly brain cancer: all tumors controlled in 3-patient Alpha Tau trial Stock Titan
Testosterone slows glioblastoma growth in men - healthcare-in-europe.com
Testosterone slows glioblastoma growth in men healthcare-in-europe.com
Jason Collins: I have Stage 4 glioblastoma - ESPN
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent...
Brain Cancer Canada Awards $100,000 “The Emily McIntosh - GlobeNewswire
Brain Cancer Canada Awards $100,000 “The Emily McIntosh GlobeNewswire
Alireza Mansouri: Major Breakthrough in Male-Bias in Glioblastoma Biology - Oncodaily
Alireza Mansouri: Major Breakthrough in Male-Bias in Glioblastoma Biology Oncodaily
NBA news: Jason Collins passes away at 47 from Stage 4 glioblastoma - ClutchPoints
NBA news: Jason Collins passes away at 47 from Stage 4 glioblastoma ClutchPoints
Focused Ultrasound for Glioblastoma (GBM): Clinical Results and Follow-On Trial in Taiwan - Focus...
Focused Ultrasound for Glioblastoma (GBM): Clinical Results and Follow-On Trial in Taiwan Focused Ultrasound Foundation
Androgen loss accelerates brain tumour growth via HPA axis activation - Nature
Androgen loss accelerates brain tumour growth via HPA axis activation Nature
Alpha Tau (DRTS) shows early Alpha DaRT results in recurrent GBM trial - Stock Titan
Alpha Tau (DRTS) shows early Alpha DaRT results in recurrent GBM trial Stock Titan
Biomarkers predict patients with glioblastoma who will survive longer after treatment with cancer...
Biomarkers predict patients with glioblastoma who will survive longer after treatment with cancer-targeting virus UT MD Anderson
Jason Collins, the NBA’s first openly gay player, dies from brain cancer at age 47 - TheGrio
Jason Collins, the NBA’s first openly gay player, dies from brain cancer at age 47 TheGrio
A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of...
Local therapeutic platform prevents postsurgical GBM recurrence by diminishing GICs and reshaping...
Jason Collins cause of death: Glioblastoma battle in focus as NBA's first openly gay player passe...
Jason Collins cause of death: Glioblastoma battle in focus as NBA's first openly gay player passes away | Hindustan Times Hindustan Times
Jason Collins, former NBA player, dies at 47 after cancer battle - India Today
Jason Collins, former NBA player, dies at 47 after cancer battle India Today
Former Atlanta Hawks player Jason Collins dies after brain cancer diagnosis - 95.5 WSB
Former Atlanta Hawks player Jason Collins dies after brain cancer diagnosis 95.5 WSB
Deciphering the STAT3-PXN positive feedback loop in GBM, IDH-wildtype: transcriptional regulation...
Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma - Nature
Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma Nature
Early Clinical Trial Results Show Promise for Glioblastoma Immunotherapy - Harvard Medical School
Early Clinical Trial Results Show Promise for Glioblastoma Immunotherapy Harvard Medical School
Attenuation of malignant phenotype of glioblastoma following a short course of the pro-oxidant co...
Glioblastoma: Testosterone Supplements Linked to 38% Lower Risk of Death - Inside Precision Medicine
Glioblastoma: Testosterone Supplements Linked to 38% Lower Risk of Death Inside Precision Medicine
3D heterotypic models of glioblastoma reveal the impact of microglia on cellular organization and...
Glioblastoma Multiforme (GBM) Treatment Market to Grow by $1.44 Billion During 2026-2030: Strateg...
Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 ex...
Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma - Nature
Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma Nature
MIT researchers find new immunotherapeutic targets for glioblastoma - MIT News
MIT researchers find new immunotherapeutic targets for glioblastoma MIT News
Novel Strategies to Enhance Chemotherapy in Advanced Glioblastoma - Cleveland Clinic
Novel Strategies to Enhance Chemotherapy in Advanced Glioblastoma Cleveland Clinic
New glioblastoma clue could lead to therapies that weaken tumors and boost immune memory - Medica...
New glioblastoma clue could lead to therapies that weaken tumors and boost immune memory Medical Xpress
Laser Therapy for Glioblastoma Tumors - Premier Health - Dayton, Ohio
Laser Therapy for Glioblastoma Tumors Premier Health - Dayton, Ohio
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses -...
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses Science | AAAS
Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect...
Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals mal...
Alpha Tau (DRTS) reports 100% local control in early recurrent glioblastoma Alpha DaRT trial - St...
Alpha Tau (DRTS) reports 100% local control in early recurrent glioblastoma Alpha DaRT trial Stock Titan
Axonal injury is a targetable driver of glioblastoma progression - Nature
Axonal injury is a targetable driver of glioblastoma progression Nature
Personalized Glioblastoma Vaccine Shows Safety and Improves Recurrence-Free Survival in Early Tri...
Personalized Glioblastoma Vaccine Shows Safety and Improves Recurrence-Free Survival in Early Trial geneonline.com
Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies - Sci...
Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies ScienceDirect.com
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity - Nature
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity Nature
Glioblastoma at the crossroads: current understanding and future therapeutic horizons - Nature
Glioblastoma at the crossroads: current understanding and future therapeutic horizons Nature
Lab-grown organoids reveal how glioblastoma outsmarts treatment - UCLA Health
Lab-grown organoids reveal how glioblastoma outsmarts treatment UCLA Health
Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011 - N...
Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011 Nature
Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers - Nature
Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers Nature
Brain Organoid Models Pave the Way for Precision Medicine for Glioblastoma - NewYork-Presbyterian
Brain Organoid Models Pave the Way for Precision Medicine for Glioblastoma NewYork-Presbyterian
Young adult glioblastoma survivor grateful for UT MD Anderson - UT MD Anderson
Young adult glioblastoma survivor grateful for UT MD Anderson UT MD Anderson
How Glioblastoma ‘Hijacks’ the Skull — and Why Treatments Fail - Medscape
How Glioblastoma ‘Hijacks’ the Skull — and Why Treatments Fail Medscape
Efficacy and safety of low- and high-intensity focused ultrasound in glioblastoma: a systematic r...
Glioblastoma exploits ATP from leading-edge astrocytes to fuel its infiltrative growth revealed b...
Glioblastoma exploits ATP from leading-edge astrocytes to fuel its infiltrative growth revealed by spatially resolved chimeric analysis Science | AAAS
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study - Yahoo Fi...
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study Yahoo Finance
Vaccine offers new hope against incurable brain cancer - NonStop Local Billings
Vaccine offers new hope against incurable brain cancer NonStop Local Billings
Vaccine offers new hope against incurable brain cancer - Key Biscayne Portal
Vaccine offers new hope against incurable brain cancer Key Biscayne Portal
Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma - Cleveland Clinic
Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma Cleveland Clinic
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-...
Repeated Brain Tumor Sampling Uncovers Treatment Response in Patients with Glioblastoma - Mass Ge...
Repeated Brain Tumor Sampling Uncovers Treatment Response in Patients with Glioblastoma Mass General Brigham
Extremely Long-Term Glioblastoma Survival (Ten Years): A Possible Role of Immune Modulation From ...
Glioblastoma survivor: ‘You can live with cancer and still have a really good life’ - UT MD Anderson
Glioblastoma survivor: ‘You can live with cancer and still have a really good life’ UT MD Anderson
New glioblastoma models to study a devastating disease - Fred Hutchinson Cancer Center
New glioblastoma models to study a devastating disease Fred Hutchinson Cancer Center
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma - Northwestern University
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma Northwestern University
Fructose Uptake in Immune Cells Promotes Glioblastoma Growth - Northwestern University
Fructose Uptake in Immune Cells Promotes Glioblastoma Growth Northwestern University
Targeting Novel Long Non-Coding RNA May Improve Glioblastoma Treatment - Northwestern University
Targeting Novel Long Non-Coding RNA May Improve Glioblastoma Treatment Northwestern University
Latham Awarded Multiple Accolades at the 2026 GBM Awards: Africa - Latham & Watkins LLP
Latham Awarded Multiple Accolades at the 2026 GBM Awards: Africa Latham & Watkins LLP
Glioblastoma Remission Rate: What Patients Need to Know - Oncodaily
Glioblastoma Remission Rate: What Patients Need to Know Oncodaily
Alpha Tau to Host Conference Call to Discuss Interim - GlobeNewswire
Alpha Tau to Host Conference Call to Discuss Interim GlobeNewswire
UNC Researchers Show Combination Therapy Effective for Brain Cancer - UNC Health
UNC Researchers Show Combination Therapy Effective for Brain Cancer UNC Health
The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states - Nature
The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states Nature
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression - N...
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression Nature
AI Distinguishes Glioblastoma From Look-Alike Cancers During Surgery - Harvard Medical School
AI Distinguishes Glioblastoma From Look-Alike Cancers During Surgery Harvard Medical School
Alpha Tau Posts Strong Interim REGAIN Data in U.S. Recurrent Glioblastoma Trial - TipRanks
Alpha Tau Posts Strong Interim REGAIN Data in U.S. Recurrent Glioblastoma Trial TipRanks
Personalized Vaccine Shows Promise Against Aggressive Brain Cancer | Newswise - Newswise
Personalized Vaccine Shows Promise Against Aggressive Brain Cancer | Newswise Newswise
Clinical trials enrolling for EGFR amplified glioblastoma and recurrent IDH-mutant glioma - Penn ...
Clinical trials enrolling for EGFR amplified glioblastoma and recurrent IDH-mutant glioma Penn Medicine
Ketogenic Diet Influence on Glioblastoma - Froedtert & MCW
Ketogenic Diet Influence on Glioblastoma Froedtert & MCW
Starving Glioblastoma: Diet-Based Treatment Shows Promise - Inside Precision Medicine
Starving Glioblastoma: Diet-Based Treatment Shows Promise Inside Precision Medicine
Finding Answers for Glioblastoma - University of Miami
Finding Answers for Glioblastoma University of Miami
Vaccine offers new hope against incurable brain cancer - Lebanon Democrat
Vaccine offers new hope against incurable brain cancer Lebanon Democrat
26 Years and Counting: Leading-Edge Glioblastoma Treatment Gives Tom More Time - University of Mi...
26 Years and Counting: Leading-Edge Glioblastoma Treatment Gives Tom More Time University of Missouri Health Care
A Custom-Built Vaccine Is Helping the Immune System Fight the Deadliest Brain Cancer - ScienceBlo...
A Custom-Built Vaccine Is Helping the Immune System Fight the Deadliest Brain Cancer ScienceBlog.com
Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT - TipRanks
Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT TipRanks
Uncovering the special trap that steroids set for glioblastoma - Cancer Research UK - Cancer News
Uncovering the special trap that steroids set for glioblastoma Cancer Research UK - Cancer News
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblasto...
Repartitioning brain glucose: serine–nucleotide dependency sensitizes glioblastoma therapy - Nature
Repartitioning brain glucose: serine–nucleotide dependency sensitizes glioblastoma therapy Nature
Simple blood test shows promising potential for detecting glioblastoma - The Brain Tumour Charity
Simple blood test shows promising potential for detecting glioblastoma The Brain Tumour Charity
Dual-target CAR T cell therapy slows growth of aggressive brain cancer - Penn Medicine
Dual-target CAR T cell therapy slows growth of aggressive brain cancer Penn Medicine
Testosterone Slows Brain Tumor Growth, Overturning a Decades-Old Cancer Assumption - ScienceBlog.com
Testosterone Slows Brain Tumor Growth, Overturning a Decades-Old Cancer Assumption ScienceBlog.com
EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-F...
Novel directions for advancing glioblastoma care - Mayo Clinic
Novel directions for advancing glioblastoma care Mayo Clinic
Manitoba man diagnosed with brain cancer says expensive treatment device bought him more time wit...
How brain fluid flow predicts survival in glioblastoma - Medical Xpress
How brain fluid flow predicts survival in glioblastoma Medical Xpress
USC study unlocks new potential treatment for glioblastoma - Keck Medicine of USC
USC study unlocks new potential treatment for glioblastoma Keck Medicine of USC
Dual-target CAR T-cell therapy slows growth of aggressive brain cancer - Penn Today
Dual-target CAR T-cell therapy slows growth of aggressive brain cancer Penn Today
Aspartame triggers genetic changes tied to glioblastoma severity - News-Medical
Aspartame triggers genetic changes tied to glioblastoma severity News-Medical
Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’ - UF Health
Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’ UF Health
Last cell standing: world-first discovery uncovers how glioblastoma tumours dodge chemotherapy - ...
Last cell standing: world-first discovery uncovers how glioblastoma tumours dodge chemotherapy The University of Sydney
Fast, flexible, and first-in-brain: how the 5G trial is taking on glioblastoma - Cancer Research ...
Fast, flexible, and first-in-brain: how the 5G trial is taking on glioblastoma Cancer Research UK - Cancer News
‘We have to go for it’: CAR-T’s success in glioblastoma prompts call for research investment - He...
‘We have to go for it’: CAR-T’s success in glioblastoma prompts call for research investment Healio